AnodyneWiki

2-Methylbucinnazine

2-Methyl-AP-237
2-Methylbucinnazine
Molecular structure via molpic based on CDK
Physical properties
[]
286.4 g/mol [1]
2.9 [1]
Structural Identifiers
[]
C18H26N2O [1]
1-[2-methyl-4-[(E)-3-phenylprop-2-enyl]piperazin-1-yl]butan-1-one [1]
CCCC(=O)N1CCN(CC1C)C/C=C/C2=CC=CC=C2 [1]
InChI=1S/C18H26N2O/c1-3-8-18(21)20-14-13-19(15-16(20)2)12-7-11-17-9-5-4-6-10-17/h4-7,9-11,16H,3,8,12-15H2,1-2H3/b11-7+ [1]
InChIKeyCRSFXYZFNAFVFC-YRNVUSSQSA-N [1]

2-Methylbucinnazine (also known as Methyl-AP-237, Bucinnazine, 2-methyl, 2-Methyl-ap-237, 1-Butanone, 1-(2-methyl-4-(3-phenyl-2-propen-1-yl)-1-piperazinyl)-, 2-methyl AP-237, Schembl10998925 or Dea no. 9664) is a substance of the 1-cinnamylpiperazine class.

Chemistry

 []

2-Methylbucinnazine is a racemic mixture of the .

(S)-2-MethylbucinnazineGenerated by the Chemistry Development Kit (http://github.com/cdk)
(R)-2-MethylbucinnazineGenerated by the Chemistry Development Kit (http://github.com/cdk)
Stereoisomer enumberation with rdkit

2-Methylbucinnazine matches Lipinski's rule of five.

Subjective effects []

0xea / 2-Methylbucinnazine []
Routes:
  • Intravenous (0.75 - 10mg)
    Onset: 5 - 10 s
    Comeup: 30 s
    Duration: ?
  • Oral (50mg)
Salts:
  • Hydrochloride
Source:
  • 2-Methyl-AP-237: Research-chemical-vendor Netherlands
Effects:Notes:

See also []

External links []

References []

  1. National Center for Biotechnology Information. PubChem Compound Summary for CID 6447699, 2-Methylbucinnazine. Accessed June 16, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/6447699